» Articles » PMID: 39767623

New Advances in Cardiovascular Drugs: A Celebration of the 90th Birthday of Professor Akira Endo

Overview
Journal Biomedicines
Date 2025 Jan 8
PMID 39767623
Authors
Affiliations
Soon will be listed here.
Abstract

In this Special Issue, we celebrate a giant of cardiovascular pharmacology, Professor Akira Endo, on the occasion of his 90th birthday [...].

Citing Articles

Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications.

Caturano A, Rocco M, Tagliaferri G, Piacevole A, Nilo D, Lorenzo G Antioxidants (Basel). 2025; 14(1).

PMID: 39857406 PMC: 11759781. DOI: 10.3390/antiox14010072.

References
1.
Ojeda-Granados C, Campisi E, Barchitta M, Agodi A . Genetic, lifestyle and metabolic factors contributing to cardiovascular disease in the Italian population: a literature review. Front Nutr. 2024; 11:1379785. PMC: 11024791. DOI: 10.3389/fnut.2024.1379785. View

2.
Ghodeshwar G, Dube A, Khobragade D . Impact of Lifestyle Modifications on Cardiovascular Health: A Narrative Review. Cureus. 2023; 15(7):e42616. PMC: 10460604. DOI: 10.7759/cureus.42616. View

3.
Adams S, Petersen C . Precision medicine: opportunities, possibilities, and challenges for patients and providers. J Am Med Inform Assoc. 2016; 23(4):787-90. PMC: 9396673. DOI: 10.1093/jamia/ocv215. View

4.
Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X . CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther. 2023; 8(1):36. PMC: 9841506. DOI: 10.1038/s41392-023-01309-7. View

5.
Singh S, Sarma D, Verma V, Nagpal R, Kumar M . Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders. Biochem Biophys Res Commun. 2023; 682:1-20. DOI: 10.1016/j.bbrc.2023.09.064. View